leisure time -WSS

leisure time

author：explore 2025-08-12 09:09:40 - browse：845

Vivistim and Lead — A small Texas company is testing whether pairing vagus nerve stimulation with rehabilitation exercise can restore movement in people who have had a stroke. STAT/MicroTransponder, Inc.

Despite being forced by Hurricane Irma to close its outpatient facilities for several days, the Mayo Clinic in Jacksonville, Fla., is expected to forge ahead this month with a pivotal clinical trial testing whether an electrical implant can rewire the brains of stroke patients so they can use their arms and hands again.

If the patients who receive implants regain significantly more function than those who get only standard rehabilitation, it will show that stroke-damaged brain circuits can be bypassed like shorts in a circuit board, with healthy neurons coaxed into performing the job of those fried by stroke.

Although the results might not be make-or-break for the little 11-year-old Texas company sponsoring the trial (called MicroTransponder, the company’s also testing whether an electrical implant can alleviate tinnitus), there will be more evidence of whether “electroceuticals” — electrical stimuli tailored to treat diseases — work beyond their current use in controlling pain and a few other conditions or will fall short of the buzz surrounding them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： BridgeBio heart drug succeeds in pivotal study

explore

WSS

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

Twill hunts for pharma partner to market its depression app

How to keep neuroscience’s past racism from being its future

Editas, Vertex strike deal on CRISPR

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Three trends to watch in biotech in 2024

Wikipedia

leisure time

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Continuity nursing helped my family in our darkest PICU moments

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Why health care costs have stayed mostly flat since 2010

Affirmative action in medical school literally saved lives

How to keep neuroscience’s past racism from being its future

State Dept. review finds Biden bears some blame for Afghanistan failures

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

hotspot

Flagship, Pfizer team up in deal worth up to $7 billion

Twill hunts for pharma partner to market its depression app

Lack of darker skin in textbooks, journals harms patients of color

Medicare Advantage beneficiaries sue Humana over algorithm use

Editas, Vertex strike deal on CRISPR

Why you get paid to donate plasma but not blood

focus

entertainment

explore

focus